NuWave Investment Management LLC bought a new position in shares of Danaher Co. (NYSE:DHR) in the fourth quarter, HoldingsChannel.com reports. The fund bought 9,292 shares of the conglomerate’s stock, valued at approximately $862,000. Danaher makes up about 1.0% of NuWave Investment Management LLC’s holdings, making the stock its 22nd largest holding.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. National Asset Management Inc. raised its stake in Danaher by 0.4% during the second quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock worth $318,000 after buying an additional 14 shares during the last quarter. Simmons Bank increased its stake in Danaher by 0.4% in the second quarter. Simmons Bank now owns 7,160 shares of the conglomerate’s stock valued at $604,000 after purchasing an additional 26 shares in the last quarter. Horizon Investments LLC increased its stake in Danaher by 0.4% in the second quarter. Horizon Investments LLC now owns 7,828 shares of the conglomerate’s stock valued at $648,000 after purchasing an additional 28 shares in the last quarter. WESPAC Advisors SoCal LLC increased its stake in Danaher by 1.2% in the second quarter. WESPAC Advisors SoCal LLC now owns 4,060 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 50 shares in the last quarter. Finally, TCI Wealth Advisors Inc. increased its stake in Danaher by 1.0% in the second quarter. TCI Wealth Advisors Inc. now owns 5,595 shares of the conglomerate’s stock valued at $472,000 after purchasing an additional 54 shares in the last quarter. 75.88% of the stock is owned by institutional investors and hedge funds.

In related news, CFO Daniel L. Comas sold 62,989 shares of the business’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $101.96, for a total transaction of $6,422,358.44. Following the transaction, the chief financial officer now directly owns 227,805 shares in the company, valued at $23,226,997.80. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $93.33, for a total transaction of $3,534,407.10. The disclosure for this sale can be found here. Over the last three months, insiders have sold 274,913 shares of company stock valued at $27,729,293. 12.20% of the stock is currently owned by insiders.

Several equities research analysts have weighed in on the stock. Morgan Stanley lifted their price target on shares of Danaher from $103.00 to $110.00 and gave the company an “overweight” rating in a research note on Wednesday, January 31st. Credit Suisse Group lifted their price target on shares of Danaher from $99.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Evercore ISI assumed coverage on shares of Danaher in a research note on Wednesday, January 3rd. They issued an “outperform” rating for the company. Argus lifted their price target on shares of Danaher from $100.00 to $115.00 and gave the company a “buy” rating in a research note on Thursday, February 1st. Finally, Zacks Investment Research downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $100.13.

Shares of Danaher Co. (DHR) opened at $94.46 on Monday. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39. The company has a market cap of $65,800.84, a PE ratio of 26.76, a PEG ratio of 1.99 and a beta of 1.04. Danaher Co. has a 52-week low of $78.97 and a 52-week high of $104.82.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, topping the consensus estimate of $1.16 by $0.03. The company had revenue of $5.09 billion during the quarter, compared to the consensus estimate of $4.97 billion. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The firm’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.05 earnings per share. research analysts anticipate that Danaher Co. will post 4.37 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were given a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.59%. The ex-dividend date was Thursday, December 28th. Danaher’s payout ratio is presently 15.86%.

WARNING: “9,292 Shares in Danaher Co. (DHR) Purchased by NuWave Investment Management LLC” was first posted by Daily Political and is owned by of Daily Political. If you are viewing this report on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this report can be read at https://www.dailypolitical.com/2018/02/12/9292-shares-in-danaher-co-dhr-purchased-by-nuwave-investment-management-llc.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.